A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

NCT01926769 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow accrual rate

Conditions

Previously Treated Advanced Colorectal Cancer

Interventions

DRUG: Metformin

Sponsor

Gachon University Gil Medical Center